alexa Tubular dysfunction and non-albuminuric renal disease in subjects with type 2 diabetes mellitus.
Genetics & Molecular Biology

Genetics & Molecular Biology

Journal of Molecular Biomarkers & Diagnosis

Author(s): RoblesOsorio ML, Sabath E

Abstract Share this page

Abstract INTRODUCTION: Micro-albuminuria is considered an early marker of glomerular injury in patients with diabetes but it has yet to be determined whether testing for markers of tubular injury can also identify people who are at risk of progressive renal disease. OBJECTIVE: To evaluate markers of tubular injury and renal characteristics in a sample of community treated type 2 diabetic subjects. MATERIAL AND METHODS: We carry-out an assessment of a group of community diabetic patients, anthropometric measures, creatinine clearance, HbA1c, lipid profile, the mean fast serum glucose levels, albuminuria and α1-microglobulin (α1M) urine excretion were evaluated. RESULTS: From 95 included patients, 45.2\% had α1M urinary excretion ≥ 10 μg/gCr, 23.1\% micro-albuminuria, 9.6\% macroalbuminuria and 27.2\% had a GFR < 60 mL/min. The most important risk factor associated with a1M excretion was fasting glucose level (OR 4.3, 95IC 1.7-11.1 p = 0.001); HbA1c ≥ 8\% and age were the most important risk factors associated with GFR ≤ 60 mL/min. Most of patients had uncontrolled glucose levels and 45.1\% patients with albuminuria were not receiving any drug with anti-proteinuric effects. CONCLUSIONS: Fasting glucose levels was the most important risk factor associated with tubular dysfunction; non-albuminuric presentation of CKD defined as GFR < 60 mL/min was frequent in our population, so is necessary to implement different strategies for surveillance in patients with type 2 diabetes aiming to delay progression to CKD.
This article was published in Rev Invest Clin and referenced in Journal of Molecular Biomarkers & Diagnosis

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 9th International Conference and Expo on Molecular & Cancer Biomarkers
    August 23-24, 2017 Birmingham, UK
  • 2nd International Conference on Medical Imaging and Diagnosis
    London, UK
  • 22nd International Conference on Cancer Drugs and Therapeutics
    Paris, France
  • International Conference on Oncology Nursing and Cancer Care
    Singapore City, Singapore
  • World Summit on Cell Signalling and Cancer Therapy
    Toronto, Canada
  • International Conference on Radiology and Imaging
    New York, USA

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version